Dr Rupert McShane - Ketamine for Treatment-Resistant Depression: The First 500 Infusions

Ketamine is presented as a rapid-acting intervention for patients suffering from treatment-resistant depression. Data from an NHS-based service indicates that infusions can effectively mitigate depressive symptoms and suicidal ideation, particularly in cases where conventional treatments have failed. The clinical approach integrates ketamine administration into a therapeutic framework often associated with electroconvulsive therapy. Despite its efficacy, long-term maintenance remains a hurdle in widespread medical adoption. The presentation underscores the challenges in minimizing side effects, understanding the variability in patient response, and ensuring the development of sustainable treatment protocols to prevent relapse.